Literature DB >> 29441938

UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.

S Q Ji, Y X Zhang, B H Yang.   

Abstract

UBR5 is recently recognized as a key player in a large number of prevalent cancers. In this study, we sought to explore the connection of UBR5 expression with cell proliferation, apoptosis, as well as the regulation mechanism in colon cancer cell line. SiUBR5 or oeUBR5 were separately applied to interfere the expression of UBR5. Western blot, DNA gel electrophoresis and qPCR were performed to detect the expression of UBR5 at mRNA and protein level. Then MTT and flow cytometry were used to explore the proliferation and apoptosis in a colon cancer cell line in vitro. Finally, we explored the interaction and correlation of UBR5 and P21 in the colon cancer regulation. We found that UBR5 was highly expressed in colon cancer not only at mRNA level but also at protein level. Moreover, UBR5 can promote the growth of colon cancer cells, and inhibit apoptosis. The mechanism exploration proved that UBR5 can degrade P21 via ubiquitination. All these findings suggest that UBR5 may be involved in progression of colon cancer and could be a new therapeutic target for this disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29441938     DOI: 10.1691/ph.2017.7433

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  11 in total

1.  Combining UBR5 and CD163+ tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients.

Authors:  Chao Wang; TianYu Hong; Yuning Wang; Guang Peng; Yongwei Yu; Jing Zhang; Dong Zhuo; Jingcun Zheng; Xiaojing Ma; Xingang Cui
Journal:  Cancer Immunol Immunother       Date:  2021-03-12       Impact factor: 6.968

2.  CircUBR5 acts as a ceRNA for miR-1179 to up-regulate UBR5 and to promote malignancy of triple-negative breast cancer.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

3.  UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer.

Authors:  Bingbing Wu; Mei Song; Qun Dong; Gang Xiang; Jing Li; Xiaojing Ma; Fang Wei
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

4.  HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways.

Authors:  Tianchi Chen; Hechen Huang; Yuan Zhou; Lei Geng; Tian Shen; Shengyong Yin; Lin Zhou; Shusen Zheng
Journal:  J Exp Clin Cancer Res       Date:  2018-08-15

Review 5.  p21 in Cancer Research.

Authors:  Bahar Shamloo; Sinem Usluer
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

6.  UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.

Authors:  Kumar Saurabh; Parag P Shah; Mark A Doll; Leah J Siskind; Levi J Beverly
Journal:  BMC Cancer       Date:  2020-08-31       Impact factor: 4.430

7.  CRlncRC: a machine learning-based method for cancer-related long noncoding RNA identification using integrated features.

Authors:  Xuan Zhang; Jun Wang; Jing Li; Wen Chen; Changning Liu
Journal:  BMC Med Genomics       Date:  2018-12-31       Impact factor: 3.063

8.  The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.

Authors:  Neel Dhingani; Conghui Guo; Jie Pan; Qi Li; Neil Warner; Sasha Jardine; Gabriella Leung; Daniel Kotlarz; Claudia Gonzaga-Jauregui; Christoph Klein; Scott B Snapper; Víctor Manuel Navas-López; Aleixo M Muise
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

9.  Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.

Authors:  Minghe Lv; Xibing Zhuang; Qi Zhang; Yunfeng Cheng; Duojiao Wu; Xiangdong Wang; Tiankui Qiao
Journal:  Cell Biol Toxicol       Date:  2020-06-20       Impact factor: 6.691

10.  MicroRNA-361-5p slows down gliomas development through regulating UBR5 to elevate ATMIN protein expression.

Authors:  Mingming Zhang; Mengqiang Yu; Jiaoying Jia; Zhu Ouyang; Ming Wang; Wenjia Ma; Min Liu
Journal:  Cell Death Dis       Date:  2021-07-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.